VAD chemotherapy as remission induction for multiple myeloma.

A total of 142 patients with multiple myeloma received VAD as remission induction therapy. Seventy-five were previously untreated and 67 had relapsed (31) or refractory disease (36). Vincristine (total dose 1.6 mg) was infused with doxorubicin 36 mg m-2 by continuous ambulatory pump over 4 days. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Anderson, H., Scarffe, J. H., Ranson, M., Young, R., Wieringa, G. S., Morgenstern, G. R., Fitzsimmons, L., Ryder, D.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1995
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033610/
https://www.ncbi.nlm.nih.gov/pubmed/7841049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033610/
https://www.ncbi.nlm.nih.gov/pubmed/7841049

Ejemplares similares